Rejubion Injection

Composition: Each 2 ml contains Methylcobalamin 1000 mcg + Pyridoxine Hydrochloride 100 mg + Nicotinamide 100 mg + D-Panthenol 50 mg + Benzyl Alcohol 2% v/v + Water for Injection

Rejubion Injection from DrugsWell is an injectable neuro-vitamin formulation created for patients who need medically supervised B-vitamin support. It is designed for situations where oral supplementation may not be sufficient, suitable, or preferred by the treating doctor.

Nerve-related vitamin deficiency symptoms can affect daily comfort in subtle but troubling ways. Patients may complain of numbness, tingling, burning sensation, weakness, tiredness, heaviness in limbs, or reduced nerve comfort. In such cases, proper diagnosis and medical guidance are important because similar symptoms can have different causes, including diabetes, nutritional deficiency, nerve compression, long-term medicine use, or other health conditions.

Rejubion Injection contains a combination of important B vitamins. Methylcobalamin supports vitamin B12 replenishment and nerve health. Pyridoxine Hydrochloride provides vitamin B6 support. Nicotinamide contributes vitamin B3 support, while D-Panthenol provides vitamin B5 support. Together, the formulation is positioned for doctor-guided neuro-vitamin care.

For doctors, Rejubion Injection offers a practical injectable option for patients requiring structured B-vitamin support, especially where nerve health, deficiency correction, or supportive neurological care is part of the treatment plan. It can be used as advised after assessing the patient’s symptoms, medical history, diet, associated conditions, and ongoing medicines.

For patients, Rejubion Injection should not be understood as a routine energy injection or general weakness treatment. It is a prescription-based injectable vitamin support product and should be used only under medical supervision. The dose, frequency, and duration should be decided by the doctor.

Patients should inform their doctor about allergies, pregnancy, breastfeeding, kidney or liver concerns, diabetes, ongoing medicines, or any previous reaction to injections. Any rash, swelling, breathing difficulty, dizziness, or unusual discomfort after injection should be reported immediately.